摘要
目的:观察豁痰化瘀中药对冠心病非PCI患者血浆光抑素-C(Cys C)水平的影响,确定豁痰化瘀中药对血管内粥样斑块的治疗作用。方法:80例患者随机分为对照组和治疗组,对照组采用单纯西药治疗,治疗组除西药外加用豁痰化瘀中药,观察两组临床疗效及血浆Cys C水平的变化。结果:两组治疗后Cys C均较治疗前降低(P<0.01),治疗组较对照组降低更显著(P<0.01)。结论:两种治疗方法均可降低Cys C水平,加用豁痰化瘀中药比单纯运用西药降低血浆Cys C水平效果明显。
Objective: To observe the influence of eliminating phlegm and removing blood stasis therapy on light inhibition-C in plasma of patients with coronary heart disease without PCI, and confirm the curative effect of drugs for eliminating phlegm and removing blood stasis in the treatment of intravascular atheromatous plaque. Methods: 80 patients were randomly divided into control group and treatment group. Patients in control group were treated with western medicine alone, and patients in treatment group were treated with drugs for eliminating phlegm and removing blood stasis based on the treatment of western medicine. The light inhibition-C level in plasma and clinical curative effect of patients in the two groups were observed, Results: The light inhibition-C level in plasma of patients of the two groups were both decreased after treatment, and the curative effect of treatment group was more significant compared with control group (P〈0.01). Conclusion: The two therapies could reduce the light inhibition-C level, and the curative effect in light inhibition-C level of combination with drugs for eliminating phlegm and removing blood stasis and western medicine is superior to that of western medicine alone.
出处
《中华中医药杂志》
CAS
CSCD
北大核心
2015年第8期2872-2873,共2页
China Journal of Traditional Chinese Medicine and Pharmacy
关键词
豁痰化瘀法
冠心病非PCI患者
光抑素-C
Eliminating phlegm and removing blood stasis therapy
Coronary heart disease patients without PCI
Light inhibition-C